2004 PDR Nurse's Drug Handbook: The Information Standard for Prescription Drugs and Nursing Considerations - Tapa blanda

The most practical tool in drug information for nurses, the PDR is a comprehensive resource of over 1,000 monographs that include action/kinetics; uses; interactions; overdose management; contraindications; nursing considerations; and patient teaching. New features include an expanded Bioterrorism Appendix and bonus drug monographs on the website, nursespdr.com.

The most practical tool in drug information for nurses, the PDR is a comprehensive resource of over 1,000 monographs that include action/kinetics; uses; interactions; overdose management; contraindications; nursing considerations; and patient teaching. New features include an expanded Bioterrorism Appendix and bonus drug monographs on the website, nursespdr.com. The PDR Nurse's Drug Handbook is designed with the practicing nurse in mind. It's lightweight and portable, puts essential drug data at your fingertips, and offers crystal-clear explanations of the information you need to do your job effectively. Published in cooperation with Delmar Publishers, the 2004 edition of the PDR Nurse's Drug Handbook is easier and quicker to use than ever! *Quick and easy reference to vital drug data. Now conveniently arranged in a handy A-to-Z format, the PDR Nurse's Drug Handbook provides complete, alphabetically arranged descriptions of each drug, including contents, dosage, side effects, overdose symptoms, and treatments. *Free Internet updates (instructions included with book). *Accuracy unmatched in the industry. PDR is the world's best-selling drug reference, with a reputation for accuracy and depth of content unduplicated by any other publication. PDRr Nurse's Drug Handbook(tm) is based on the same reliable, detailed data that has made PDR the leader in the field. Among the new drugs featured in this edition are: Zetia (ezetimibe), the first of a new class of lipid-lowering compounds that selectively inhibits intestinal absorption of cholesterol and related phytosterols. Strattera (atomoxetine HCl), the first selective norepinephrine reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder (ADHD). Forteo (teriparatide[rDNA origin]), a new recombinant human parathyroid hormone for the treatment of postmenopausal women with osteoporosis, and to increase bone mass in men with primary or hypogonadal osteoporosis.